Standing Order
All companies

Defense

Lockheed Martin Corporation

LMTNYSEdiversified
Market cap$134B
Conviction5/ 5
HQBethesda, Maryland, USA
View full dashboard

For informational purposes only. Not financial advice, not a recommendation to buy or sell any security. Standing Order is a directory and research project, not an advisory service.

Price · 1Y

$582.60

+21.7%

Thesis

Lockheed Martin is the largest defense prime, anchored by the F-35 program and a deep missiles and fire-control franchise. It is also a leading developer of U.S. hypersonic strike systems.

Catalysts

  • F-35 sustainment and international orders
  • Hypersonic weapon program awards
  • Missile-defense demand tailwinds

Recent events

Material filings, federal awards, and regulatory activity. Impact is scored against market cap.

  • Jul 23
    Financial resultsSEC

    Lockheed Martin filed 8-K (items 2.02, 9.01) reporting results of operations.

  • Jul 22
    Contract awardFederal award

    Lockheed Martin awarded $675M DoD contract for MK21A re-entry vehicle EMD early production and deployment.

    $675M
  • Jul 21
    Contract awardFederal award

    Lockheed Martin awarded $1.26B DoD contract for MK21A re-entry vehicle EMD early production and deployment.

    $1.3B
  • Jul 15
    Contract awardFederal award

    Lockheed Martin awarded $291M DoD contract N0003025C6045 for FY25 UK Trident Fleet Support

    $291M
  • Jun 30
    Contract awardFederal award

    DoD contract award of $125.2M for correction of known/unknown deficiencies on Lots 6-14.

    $125M
  • Jun 26
    Contract awardFederal award

    Lockheed Martin awarded $696M DoD contract (W31P4Q24F0144) for HIMARS systems for US Army and FMS.

    $696M
  • Jun 26
    Contract awardFederal award

    Lockheed Martin awarded $333.1M DoD contract HQ027619C0001 for AEGIS BMD 6.0 WS DEVELOPMENT

    $333M
  • Jun 26
    Contract awardFederal award

    Department of Defense awards $226M contract (HQ014714C0004) to Lockheed Martin for highly specialized services.

    $226M

Not financial advice — research and opinion only. Disclosures